HBP Share Price

Open 0.95 Change Price %
High 0.95 1 Day 0.00 0.00
Low 0.95 1 Week -0.04 -4.04
Close 0.95 1 Month -0.05 -5.00
Volume 550 1 Year -1.00 -51.28
52 Week High 2.25
52 Week Low 0.70
HBP Important Levels
Resistance 2 0.95
Resistance 1 0.95
Pivot 0.95
Support 1 0.95
Support 2 0.95
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
BBD-B 2.39 -3.63%
HCG 19.00 27.18%
HCG 19.00 27.18%
HCG 19.00 27.18%
HCG 19.00 27.18%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
HE 0.04 100.00%
HE 0.04 100.00%
TVI 0.02 100.00%
LRT-UN 0.04 100.00%
HCG 19.00 27.18%
HCG 19.00 27.18%
HCG 19.00 27.18%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
DNT 0.06 -14.29%
BLU 0.36 -12.20%
GGA 0.08 -11.11%
CTU-A 0.19 -9.52%
DEJ 0.14 -6.67%
DEJ 0.14 -6.67%
BU 1.45 -6.45%
GEN 0.15 -6.25%
GEN 0.15 -6.25%
More..

Helix BioPharma Corp (TSE: HBP)

HBP Technical Analysis 4
As on 21st Jun 2017 HBP Share Price closed @ 0.95 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.60 & Sell for SHORT-TERM with Stoploss of 1.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
HBP Target for June
1st Target up-side 1.15
2nd Target up-side 1.26
3rd Target up-side 1.37
1st Target down-side 0.85
2nd Target down-side 0.74
3rd Target down-side 0.63
HBP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.helixbiopharma.com
HBP Address
HBP
305 Industrial Parkway South
Unit 3
Aurora, ON L4G 6X7
Canada
Phone: 905-841-2300
Fax: 905-841-2244
HBP Latest News
Helix Biopharma Corp (HBP.TO) Needle Moving on Volume   The Times   - 21st Jun 17
Helix Biopharma Corp (HBP.TO) Shares Needle Moving 4.21%   The Times   - 20th Jun 17
Helix BioPharma Corp. Announces Fiscal Third Quarter 2017 Results   Marketwired (press release)   - 14th Jun 17
Helix Biopharma Corp. (HBP) Analysts See $0.00 EPS; Numeric Investors Has ...   Key Gazette   - 12th Jun 17
Helix BioPharma Corp. Announces Fiscal Second Quarter 2017 Results and Closing ...   Marketwired (press release)   - 17th Mar 17
Helix BioPharma Corp. Announces Agreement in Principle With National Research ...   Marketwired (press release)   - 19th Jul 16
Helix BioPharma Corp. Announces L-DOS47 Immuno-Oncology Scientific ...   Marketwired (press release)   - 27th Jun 16
Helix BioPharma Corp. Opens the Market   MarketWatch   - 26th May 16
Helix BioPharma Corp. Announces CEO Change   Marketwired (press release)   - 30th Mar 16
0.666   MarketWatch   - 22nd May 13
Interactive Technical Analysis Chart Helix BioPharma Corp ( HBP TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Helix BioPharma Corp
HBP Business Profile
Helix BioPharma Corp., a biopharmaceutical company, develops drugs for the prevention and treatment of cancer based on its proprietary technologies. The company focuses on the development of L-DOS47 that is in phase I/II clinical trial for the treatment of inoperable, locally advanced, and recurrent or metastatic non-small cell lung cancer; and Topical Interferon Alpha-2b, which has completed phase II study for the treatment of low-grade cervical lesions and ano-genital warts caused by human papilloma virus infections. It also offers DOS47, a patented oncology platform technology that derives a therapeutic pharmacological effect by acting upon a naturally occurring substance in the body. Helix BioPharma Corp. is based in Aurora, Canada.